Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swiss PACK-CXL Multicenter Trial
NCT02717871Phase 3Completed
- Start
- Mar 2016
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in infectious keratitis (IK) (2 arms). Primary endpoint: Time to re-epithelialization of the corneal surface at 28 days. Started Mar 2016; status: completed.
02
Conditions
infectious keratitis (IK)
Beyond the preview
Go deeper on NCT02717871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717871.